Serological and molecular diagnosis of hepatitis delta virus infection: results of a French national quality control study

Ségolène BRICHLER, Frédéric LE GAL, F Neri-Pinto, W Mansour, D Roulot, S Laperche, Emmanuel GORDIEN,

J Clin Microbiol. 01/05/2014;52(5) : 1694-1697 10.1128/JCM.03521-13. 12/02/2014

Increasing prevalence of HDV/HBV infection over 15 years in France

A Servant-Delmas, Frédéric LE GAL, P Gallian, Emmanuel GORDIEN, S Laperche,

J Clin Virol. 01/02/2014;59(2) : 126-128 10.1016/j.jcv.2013.11.016 07/12/2013

Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study

F Lunel-Fabiani, W Mansour, AO Amar, M Aye, Frédéric LE GAL, FZ Malick, L Baidy, Ségolène BRICHLER, P Veillon, A Ducancelle, Emmanuel GORDIEN, M Rosenheim,

J Infect. 01/11/2013;67(5) : 448-457 10.1016/j.jinf.2013.06.008 22/06/2013

African, Amerindian and European hepatitis B virus strains circulate on the Caribbean Island of Martinique

Ségolène BRICHLER, G Lagathu, MA Chekaraou, Frédéric LE GAL, A Edouard, P Deny, R Cesaire, Emmanuel GORDIEN,

J Gen Virol. 01/10/2013;94(Pt10) : 2318-2329 10.1099/vir.0.055459-0 24/07/2013

Commercial real-time reverse transcriptase PCR assays can underestimate or fail to quantify hepatitis delta virus viremia

Ségolène BRICHLER, Frédéric LE GAL, A Butt, S Chevret, Emmanuel GORDIEN,

Clin Gastroenterol Hepatol. 01/06/2013;11(6) : 734-740 10.1016/j.cgh.2013.01.025 01/02/2013